Elexacaftor, tezacaftor and ivacaftor (ETI)

Study	Country Study period	Population source	Exposure definition	Non-exposure definition	Sample size	Rmk
Etherington, 2024	United Kingdom 2010 - 2023	Women with Cystic Fibrosis (wwCF) who delivered between 2010 and 2023.	Women with Cystic Fibrosis (wwCF) who became pregnant and continued elexacaftor/tezacaftor/ ivacaftor (ETI) during pregnancy.	unexposed, sick Women with Cystic Fibrosis (wwCF) who became pregnant during the pre modulator era.	24 / 26

Study	Country Study period	Case	Control	Sample size	Rmk

1 study, not fulfilled eligibility criteria, were excluded. See excluded tab for the list of these studies and reason of exclusion.